LabGenius

Looking to the future, the next wave of major scientific breakthroughs will be unlocked by technology platforms that are capable of combining the very best of human ingenuity and machine intelligence.

Armed with this knowledge, our mission is to accelerate the discovery of next-generation therapeutic antibodies. To do this, we’re pioneering the development of a smart robotic platform (EVA™) that’s capable of designing, conducting and — critically — learning from its own experiments. 

We believe this approach will radically improve the drug discovery process, making the generation of advanced antibody therapeutics faster.